GALT icon

Galectin Therapeutics

45 hedge funds and large institutions have $8.34M invested in Galectin Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$784K
Puts
$272K
Net Calls
Net Calls Change

Top Buyers

1 +$484K
2 +$351K
3 +$298K
4
Morgan Stanley
Morgan Stanley
New York
+$191K
5
DADC
D.A. Davidson & Co
Montana
+$175K

Top Sellers

1 -$31K
2 -$13.4K
3 -$9.21K
4
Bank of America
Bank of America
North Carolina
-$7.76K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.96K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.84M
2
$1.7M
3
$1.01M
4
$447K
5
$351K
6
$299K
7
$298K
8
$274K
9
$250K
10
$206K
11
$199K
12
$198K
13
$165K
14
$130K
15
$130K
16
$115K
17
$80K
18
$70K
19
$66K
20
$60K
21
$56K
22
$54K
23
$48K
24
$40K
25
$38K